Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $5.32 +0.18 (+3.50%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$5.34 +0.01 (+0.28%) As of 05/2/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance 5 Day Performance+8.57%1 Month Performance+55.10%3 Month Performance+46.96%6 Month Performance-6.67%Year-To-Date Performance+40.74%1 Year Performance+162.07% Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AMLX Stock Chart for Sunday, May, 4, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$5.14$5.32+3.50%$5.46$5.17759,329 shs$473.93 million05/01/2025$5.11$5.14+0.59%$5.55$5.031.47 million shs$457.89 million04/30/2025$4.90$5.11+4.29%$5.17$4.831.04 million shs$452.76 million04/29/2025$5.01$4.90-2.20%$5.12$4.78546,850 shs$434.15 million04/28/2025$5.36$5.01-6.53%$5.41$4.98547,092 shs$443.90 million04/25/2025$5.24$5.36+2.29%$5.47$5.15664,842 shs$474.91 million04/24/2025$5.06$5.24+3.56%$5.28$4.99454,540 shs$464.27 million04/23/2025$4.92$5.06+2.85%$5.24$4.901.08 million shs$448.33 million04/22/2025$4.23$4.92+16.31%$4.95$4.281.94 million shs$435.92 million04/21/2025$3.98$4.23+6.28%$4.32$3.94895,375 shs$374.79 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$3.98$3.98$4.12$3.80724,313 shs$352.64 million04/17/2025$3.82$3.98+4.19%$4.12$3.80724,313 shs$352.64 million04/16/2025$3.88$3.82-1.55%$3.93$3.79495,459 shs$338.46 million04/15/2025$3.90$3.88-0.51%$4.01$3.81404,277 shs$343.78 million04/14/2025$3.65$3.90+6.85%$4.05$3.691.49 million shs$345.55 million04/11/2025$3.49$3.65+4.58%$3.68$3.42562,243 shs$323.40 million04/10/2025$3.49$3.49$3.54$3.30462,040 shs$309.22 million04/09/2025$3.31$3.49+5.44%$3.58$3.111.11 million shs$309.22 million04/09/2025$3.31$3.49+5.44%$3.58$3.111.11 million shs$309.22 million04/08/2025$3.46$3.31-4.34%$3.65$3.26524,964 shs$293.27 million04/08/2025$3.46$3.31-4.34%$3.65$3.26524,964 shs$293.27 million04/07/2025$3.43$3.46+0.87%$3.60$3.171.17 million shs$306.56 million04/04/2025$3.51$3.43-2.28%$3.56$3.26914,194 shs$303.91 million04/03/2025$3.78$3.51-7.14%$3.73$3.42721,334 shs$310.99 million Related Companies ANI Pharmaceuticals Stock Chart Apogee Therapeutics Stock Chart Immunocore Stock Chart Kiniksa Pharmaceuticals Stock Chart Disc Medicine Stock Chart ARS Pharmaceuticals Stock Chart Edgewise Therapeutics Stock Chart Vera Therapeutics Stock Chart Travere Therapeutics Stock Chart Structure Therapeutics Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy amlx Stock Free amlx Stock Alerts